29 related articles for article (PubMed ID: 18594013)
21. Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer.
Papewalis C; Wuttke M; Seissler J; Meyer Y; Kessler C; Jacobs B; Ullrich E; Willenberg HS; Schinner S; Baehring T; Scherbaum WA; Schott M
Clin Cancer Res; 2008 Jul; 14(13):4298-305. PubMed ID: 18594013
[TBL] [Abstract][Full Text] [Related]
22. [Current status and prospects for targeted therapy for thyroid cancer].
Shimizu K; Mimura T; Harada T; Tanaka S
Gan To Kagaku Ryoho; 1994 May; 21(6):743-8. PubMed ID: 8185329
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
Kunnimalaiyaan M; Chen H
Oncologist; 2007 May; 12(5):535-42. PubMed ID: 17522241
[TBL] [Abstract][Full Text] [Related]
24. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
Messina M; Robinson BG
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
[TBL] [Abstract][Full Text] [Related]
25. Endocrine diffuse system. Histological and functional aspects interrelated with tumoral pathology.
Luca IC
Rom J Morphol Embryol; 1998; 44(1-4):17-22. PubMed ID: 15678838
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
